BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+5.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$531M
AUM Growth
-$19.6M
(-3.6%)
Cap. Flow
-$35M
Cap. Flow
% of AUM
-6.59%
Top 10 Holdings %
Top 10 Hldgs %
30.22%
Holding
139
New
9
Increased
20
Reduced
40
Closed
15
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$8.11M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$6.25M |
| 3 |
Stryker
SYK
|
$6.23M |
| 4 |
AMSG
Amsurg Corp
AMSG
|
$5.74M |
| 5 |
Hologic
HOLX
|
$5.44M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$6.99M |
| 2 |
Gilead Sciences
GILD
|
$6.41M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$5.64M |
| 4 |
Biogen
BIIB
|
$5.33M |
| 5 |
STJ
St Jude Medical
STJ
|
$4.84M |
Sector Composition
| 1 | Healthcare | 92.67% |
| 2 | Financials | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Teleflex
TFX
$5.57B
| $1.78M | 0.33% |
10,010
| – | – |
|
77
Pfizer
PFE
$141B
| $1.76M | 0.33% |
52,700
-63,240
| -55% | -$2.11M |
|
78
Bristol-Myers Squibb
BMY
$96.7B
| $1.69M | 0.32% |
23,000
-37,000
| -62% | -$2.72M |
|
|
VAR
79
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.65M | 0.31% |
22,808
-19,386
| -46% | -$1.4M |
|
|
ZLTQ
80
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $1.64M | 0.31% |
60,000
-15,000
| -20% | -$410K |
|
81
Healthcare Services Group
HCSG
$1.14B
| $1.58M | 0.3% |
38,100
-11,900
| -24% | -$493K |
|
82
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$727M
| $1.56M | 0.29% |
2,759
+1,750
| +173% | +$988K |
|
83
Agios Pharmaceuticals
AGIO
$2.36B
| $1.51M | 0.28% |
36,000
-18,000
| -33% | -$754K |
|
|
RDUS
84
DELISTED
Radius Health, Inc.
RDUS
| $1.47M | 0.28% |
40,000
| – | – |
|
85
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.46M | 0.27% |
45,000
| – | – |
|
86
Inovio Pharmaceuticals
INO
$144M
| $1.43M | 0.27% |
12,917
-9,166
| -42% | -$1.02M |
|
|
JUNO
87
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.42M | 0.27% |
37,000
| – | – |
|
88
Ultragenyx Pharmaceutical
RARE
$3.04B
| $1.37M | 0.26% |
28,000
+18,000
| +180% | +$880K |
|
89
Alnylam Pharmaceuticals
ALNY
$58.6B
| $1.33M | 0.25% |
24,000
| – | – |
|
90
Exelixis
EXEL
$9.95B
| $1.33M | 0.25% |
170,000
| – | – |
|
|
BLUE
91
DELISTED
bluebird bio
BLUE
| $1.26M | 0.24% |
2,239
| – | – |
|
|
ALR
92
DELISTED
Alere Inc
ALR
| $1.25M | 0.24% |
+30,000
| New | +$1.25M |
|
|
WMGI
93
DELISTED
Wright Medical Group Inc
WMGI
| $1.22M | 0.23% |
70,309
| – | – |
|
94
Prothena Corp
PRTA
$452M
| $1.08M | 0.2% |
31,000
| – | – |
|
95
Labcorp
LH
$22.8B
| $1.04M | 0.2% |
9,312
-2,328
| -20% | -$261K |
|
|
AAC
96
DELISTED
AAC Holdings, Inc.
AAC
| $1.03M | 0.19% |
+45,000
| New | +$1.03M |
|
97
DaVita
DVA
$9.72B
| $1.01M | 0.19% |
13,000
-7,000
| -35% | -$541K |
|
|
EVHC
98
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $989K | 0.19% |
+13,026
| New | +$989K |
|
99
AbbVie
ABBV
$374B
| $929K | 0.17% |
15,000
| – | – |
|
|
CPHD
100
DELISTED
Cepheid Inc
CPHD
| $923K | 0.17% |
+30,000
| New | +$923K |
|